Enanta Pharmaceuticals, Inc. to Present at the Wells Fargo Securities 2013 Healthcare Conference
6/14/2013 7:03:51 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will present a corporate overview followed by a Q&A session and participate in a Hepatitis C panel discussion on June 18, 2013 at the Wells Fargo Securities 2013 Healthcare Conference in Boston, MA. The panel discussion will take place at 10:00 a.m. ET and the presentation will take place at 11:10 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.
comments powered by